Novabay pharmaceuticals stock forecast
WebStock Price Forecast The 2 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 15.00 and a low estimate of... NovaBay Pharmaceuticals Inc (NYSE American:NBY) 1.50. Delayed Data. As of … Annual Data Quarterly Data; All Currency in US Dollars 4 Year Trend; 2015 2016 2024 … NBY NovaBay Pharmaceuticals Inc: $3.1M: NM-8.11% ... Most stock quote data … NovaBay Pharmaceuticals Inc (NYSE American:NBY) Real-Time Quotes. 1.70. … NovaBay Pharmaceuticals Inc (NYSE American:NBY) 1.43. Delayed Data. As of … http://mbstaging.marketbeat.com/stocks/NYSEAMERICAN/NBY/
Novabay pharmaceuticals stock forecast
Did you know?
WebNovaBay Pharmaceuticals Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 47 means that 53% of … WebNovaBay Pharmaceuticals, Inc. Analyst Report: Johnson & Johnson Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical ...
Web1 day ago · NovaBay Pharmaceuticals (NBY) (Real Time Quote from BATS) $1.59 USD +0.09 (6.00%) Updated Apr 13, 2024 01:54 PM ET Add to portfolio Zacks Rank: Style Scores: NA Value NA Growth NA Momentum... WebApr 13, 2024 · NovaBay Pharmaceuticals, Inc Stock Earnings Report Current P/E ratio: -0.436 Price (Mar 17, 2024, EOD): $1.50 (Find current average P/E ratios for all sectors below ) NBY Upcoming Earnings (Q1 2024) NBY Analysts Price Targets Currently no data available. About NovaBay Pharmaceuticals, Inc
WebMar 14, 2024 · Stock Data. View Stock Detail. COMPANY. NovaBay Pharmaceuticals, Inc. NYSE AMEX: NBY. Russell Microcap Index component. IR CONTACT. LHA Investor Relations Jody Cain [email protected] 310-691-7100. TRANSFER AGENT. Computershare Investor Services Toll Free in the US +1 800 962 4284 Telephone +1 303 262 0600 WebJan 4, 2024 · Researching NovaBay Pharmaceuticals? Get The Latest NBY Stock Forecast, Price Target, Earnings Estimates, and Headlines at MarketBeat.
WebJan 14, 2024 · Jan 14, 2024 1:23PM EST NovaBay Pharmaceuticals Inc. ( NBY) shares closed today at 0.8% above its 52 week low of $0.34, giving the company a market cap of $15M. The stock is currently down...
WebEarnings Preview For NovaBay Pharmaceuticals Nov. 11, 2024 at 3:37 p.m. ET on Benzinga.com Stocks That Hit 52-Week Lows On Tuesday Oct. 25, 2024 at 2:22 p.m. ET on Benzinga.com Why Missfresh... shareholder ratification of directors actionsWebNovaBay Pharmaceuticals, Inc About Technology Brands Investors News Contact TOP About Management Team Board of Directors Contact Us Technology Pure HOCI Brands … shareholder purchase agreement templateWebFor NovaBay Pharmaceuticals stock forecast for 2024, 10 predictions are offered for each month of 2024 with average NovaBay Pharmaceuticals stock forecast of $3.78, a high forecast of $5.69, and a low forecast of $2.31. The average NovaBay Pharmaceuticals stock forecast 2024 represents a 74.39% increase from the last price of $2.17000007629395. shareholder report final ruleWebNovaBay Pharmaceuticals reported Asset Turnover of 0.61 in 2024. Book Value per Share is likely to rise to 7.53 in 2024, whereas Current Ratio is likely to drop 3.11 in 2024. This module is based on analyzing investor sentiment around taking a position in NovaBay Pharmaceuticals. shareholder rights to inspect board minutesWebNovaBay Pharmaceuticals Inc Follow Share $1.60 After Hours: $1.65 (3.12%) +0.050 Closed: Apr 6, 6:48:27 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer search Compare to AcelRx Pharmaceuticals Inc... poor circulation in breastWebApr 12, 2024 · Virtual Stock Exchange; ... MGB Biopharma Limited, Microbiotix., MicuRx Pharmaceuticals, Nabriva Therapeutics, NovaBay Pharmaceuticals, NovoBiotic ... at unexpected CAGR during the forecast Period ... shareholder rights planWebMar 31, 2024 · Shares Out 1.88M 10 Day Average Volume 0.01M Dividend - Dividend Yield - Beta 2.77 YTD % Change -12.82 RATIOS/PROFITABILITY EPS (TTM) -5.73 P/E (TTM) … shareholder rights to accounts